TY - JOUR
T1 - Mediators of Anaphylaxis
AU - Ogawa, Yoshiko
AU - Grant, J. Andrew
PY - 2007/5
Y1 - 2007/5
N2 - Anaphylaxis is a life-threatening condition closely linked to IgE activation of mast cells with subsequent release of preformed mediators, including histamine, neutral proteases (tryptase and chymase), and proteoglycans (eg, heparin) from intracellular granules. These factors participate in the development of classic symptoms involving the skin, respiratory tract, circulation, and gastrointestinal system. Release of these granules is followed quickly by increased synthesis from membrane arachidonic acid of prostaglandins and leukotrienes that have an additional role in clinical symptoms. Thereafter, mast cells release numerous chemokines and cytokines that initiate recruitment and activation of additional inflammatory cells, including basophils, eosinophils, and Th2 cells.
AB - Anaphylaxis is a life-threatening condition closely linked to IgE activation of mast cells with subsequent release of preformed mediators, including histamine, neutral proteases (tryptase and chymase), and proteoglycans (eg, heparin) from intracellular granules. These factors participate in the development of classic symptoms involving the skin, respiratory tract, circulation, and gastrointestinal system. Release of these granules is followed quickly by increased synthesis from membrane arachidonic acid of prostaglandins and leukotrienes that have an additional role in clinical symptoms. Thereafter, mast cells release numerous chemokines and cytokines that initiate recruitment and activation of additional inflammatory cells, including basophils, eosinophils, and Th2 cells.
UR - http://www.scopus.com/inward/record.url?scp=34248144060&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34248144060&partnerID=8YFLogxK
U2 - 10.1016/j.iac.2007.03.013
DO - 10.1016/j.iac.2007.03.013
M3 - Review article
C2 - 17493501
AN - SCOPUS:34248144060
SN - 0889-8561
VL - 27
SP - 249
EP - 260
JO - Immunology and Allergy Clinics of North America
JF - Immunology and Allergy Clinics of North America
IS - 2
ER -